Allschwil, Switzerland – March 10, 2026Idorsia Ltd (SIX: IDIA) has entered into an exclusive agreement with Pharmalink Drug Store L.L.C for the distribution and commercialization of QUVIVIQ™ (daridorexant) – its treatment for adults with insomnia – across the…
Idorsia and Pharmalink enter into an exclusive distribution and commercialization agreement for QUVIVIQ (daridorexant) in the United Arab Emirates (UAE), Kuwait, Qatar, Oman, and Bahrain